German Institute for Quality and Efficiency in Health Care Publishes Dossier Evaluation within Early Benefit Assessment Process of PIXUVRIA

Cell Therapeutics, Inc. today announced that the private German Institute for Quality and Efficiency in Health Care has published its report on the preliminary benefit assessment of PIXUVRI as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma .

http://www.freshnews.com/news/767825/german-institute-quality-and-efficiency-health-care-iqwig-publishes-dossier-evaluation-